Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
15.16
+0.11 (0.73%)
Nov 3, 2026, 12:01 PM EST - Market open
Attovia Therapeutics Market Cap
Attovia Therapeutics has a market cap or net worth of $692.07 million as of November 3, 2026. It is the 12,271st most valuable company in the world and the 2,502nd biggest in the United States.
Market Cap
692.07M
Enterprise Value
581.27M
1-Year Change
n/a
Global Rank
Country Rank
#2,502 United States
Category
ChartMarket Cap Chart
Since the IPO on August 5, 2026, Attovia Therapeutics's market cap has decreased from $731.49M to $692.07M, a decrease of -5.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 692.07M | 0.73% |
| Nov 2, 2026 | 687.05M | -0.92% |
| Oct 30, 2026 | 693.44M | -0.52% |
| Oct 29, 2026 | 697.09M | -3.35% |
| Oct 28, 2026 | 721.29M | 5.33% |
| Oct 27, 2026 | 684.77M | 8.07% |
| Oct 26, 2026 | 633.64M | 0.36% |
| Oct 23, 2026 | 631.36M | -4.62% |
| Oct 22, 2026 | 661.94M | 2.26% |
| Oct 21, 2026 | 647.33M | 1.00% |
| Oct 20, 2026 | 640.94M | 1.08% |
| Oct 19, 2026 | 634.10M | 1.17% |
| Oct 16, 2026 | 626.79M | -7.10% |
| Oct 15, 2026 | 674.73M | -1.20% |
| Oct 14, 2026 | 682.94M | 1.63% |
| Oct 13, 2026 | 671.99M | 0.89% |
| Oct 12, 2026 | 666.05M | -9.99% |
| Oct 9, 2026 | 740.01M | -0.61% |
| Oct 8, 2026 | 744.57M | -0.67% |
| Oct 7, 2026 | 749.59M | -6.17% |
| Oct 6, 2026 | 798.90M | -2.75% |
| Oct 5, 2026 | 821.49M | 4.80% |
| Oct 2, 2026 | 783.83M | -3.49% |
| Oct 1, 2026 | 812.14M | 3.79% |
| Sep 30, 2026 | 782.46M | -5.62% |
| Sep 29, 2026 | 829.03M | 2.89% |
| Sep 28, 2026 | 805.74M | -0.73% |
| Sep 25, 2026 | 811.68M | -2.15% |
| Sep 24, 2026 | 829.48M | -1.89% |
| Sep 23, 2026 | 845.46M | -11.09% |
| Sep 22, 2026 | 950.92M | -2.21% |
| Sep 21, 2026 | 972.37M | -3.79% |
| Sep 18, 2026 | 1.01B | -2.60% |
| Sep 17, 2026 | 1.04B | 2.16% |
| Sep 16, 2026 | 1.02B | -6.12% |
| Sep 15, 2026 | 1.08B | -3.34% |
| Sep 14, 2026 | 1.12B | 7.59% |
| Sep 11, 2026 | 1.04B | 1.15% |
| Sep 10, 2026 | 1.03B | -1.44% |
| Sep 9, 2026 | 1.04B | -3.38% |
| Sep 8, 2026 | 1.08B | -7.40% |
| Sep 4, 2026 | 1.17B | 5.58% |
| Sep 3, 2026 | 1.10B | 4.63% |
| Sep 2, 2026 | 1.06B | 10.44% |
| Sep 1, 2026 | 956.10M | 3.83% |
| Aug 31, 2026 | 920.82M | 3.38% |
| Aug 28, 2026 | 890.70M | -3.54% |
| Aug 27, 2026 | 923.40M | 9.77% |
| Aug 26, 2026 | 841.22M | 1.24% |
| Aug 25, 2026 | 830.89M | -6.35% |
| Aug 24, 2026 | 887.26M | -0.87% |
| Aug 21, 2026 | 895.00M | 2.92% |
| Aug 20, 2026 | 869.62M | -8.72% |
| Aug 19, 2026 | 952.66M | -4.73% |
| Aug 18, 2026 | 999.99M | 2.33% |
| Aug 17, 2026 | 977.19M | 14.35% |
| Aug 14, 2026 | 854.56M | 3.55% |
| Aug 13, 2026 | 825.30M | 6.20% |
| Aug 12, 2026 | 777.10M | -3.16% |
| Aug 11, 2026 | 802.49M | -6.00% |
| Aug 10, 2026 | 853.70M | -1.64% |
| Aug 7, 2026 | 867.90M | -1.03% |
| Aug 6, 2026 | 876.93M | 19.88% |
| Aug 5, 2026 | 731.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OmniAb | 745.35M |
| ArriVent BioPharma | 733.21M |
| Wave Life Sciences | 708.05M |
| Sagimet Biosciences | 703.41M |
| Achieve Life Sciences | 702.82M |
| SL Science Holding | 684.32M |
| Apnimed | 682.74M |
| Design Therapeutics | 668.37M |